SCHEMBL13856429

SCHEMBL13856429

Cc1ccccc1NC(=O)CSc1nnc(-c2ccco2)c(-c2ccco2)n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 11/20 1.00
KMT2A Q03164 11/20 1.00
ALDH1A1 P00352 10/20 1.00
POLB P06746 10/20 1.00
KDM4E B2RXH2 9/20 1.00
MAPT P10636 8/20 1.00
HPGD P15428 5/20 1.00
APEX1 P27695 4/20 1.00
ALOX12 P18054 3/20 1.00
NR4A1 P22736 3/20 1.00
ESR2 Q92731 2/20 1.00
USP2 O75604 2/20 1.00
ESR1 P03372 1/20 1.00
HTT P42858 1/20 1.00
MCL1 Q07820 8/20 0.85
L3MBTL1 Q9Y468 7/20 0.85
BLM P54132 6/20 0.85
TDP1 Q9NUW8 6/20 0.85
THRB P10828 4/20 0.85
RECQL P46063 4/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26294531 0.86 MEN1 (0.76) MEN1KMT2AALDH1A1POLBKDM4E
SCHEMBL26295615 0.86 KMT2A (0.75) MEN1KMT2AALDH1A1POLBKDM4E
SCHEMBL26294993 0.85 MEN1 (0.73) MEN1KMT2AALDH1A1POLBKDM4E
SCHEMBL13856422 0.84 MEN1 (1.00) MEN1KMT2AALDH1A1POLBKDM4E
SCHEMBL13856578 0.84 MEN1 (1.00) MEN1KMT2AALDH1A1POLBKDM4E
SCHEMBL26293025 0.84 KMT2A (0.73) MEN1KMT2AALDH1A1POLBKDM4E
SCHEMBL26293052 0.83 MEN1 (0.71) MEN1KMT2AALDH1A1POLBKDM4E
SCHEMBL26293192 0.83 MEN1 (0.85) MEN1KMT2AALDH1A1POLBKDM4E
SCHEMBL26293177 0.81 MEN1 (0.82) MEN1KMT2AALDH1A1POLBKDM4E
SCHEMBL26293058 0.80 MEN1 (0.78) MEN1KMT2AALDH1A1POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090118135-A1 METHODS AND COMPOUNDS FOR REGULATING APOPTOSIS THE BURNHAM INSTITUTE (US) 2009-05-07 US disclosed
US-20090118135-A1 METHODS AND COMPOUNDS FOR REGULATING APOPTOSIS THE BURNHAM INSTITUTE (US) 2009-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118135-A1 METHODS AND COMPOUNDS FOR REGULATING APOPTOSIS BCL2, BAX, BAD MEN1 4323/4885KMT2A 4047/4885ALDH1A1 3724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.